I. Romics

发表

Overexpression of CD24, c-myc and Phospholipase 2A in Prostate Cancer Tissue Samples Obtained by Needle Biopsy

B. Nagy, A. Szendrői, I. Romics, 2009, Pathology & Oncology Research.

Matrix metalloproteinase‐7 as a marker of metastasis and predictor of poor survival in bladder cancer

A. Bankfalvi, M. Tötsch, K. Schmid, 2010, Cancer science.

Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk

K. Ickstadt, T. Reckwitz, M. Falkenstein, 2012, Archives of Toxicology.

Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype

K. Ickstadt, T. Reckwitz, M. Falkenstein, 2011, Pharmacogenetics and genomics.

Urinary incontinence and voiding dysfunction after radical retropubic prostatectomy (prospective urodynamic study)

I. Romics, A. Majoros, D. Bach, 2006, Neurourology and urodynamics.

Immunological studies of patients with tumours of the prostate and bladder

J. Féher, I. Romics, J. Horváth, 2005, International Urology and Nephrology.

The effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteric stones

B. Jelaković, G. Blaskó, I. Romics, 2003, BJU international.

How Can Cancer-Associated Anemia Be Moderated with Nutritional Factors and How Do Beta Vulgaris L. Ssp. Esculenta Var. Rubra Modify the Transmethylation Reaction in Erythrocytes in Cancerous Patients?

A. Horváth, A. Blázovics, Á. Szilvás, 2012 .

Experience with prostate-specific antigen in prostatic carcinoma

I. Romics, D. Bach, 2007, International Urology and Nephrology.

A new concept for active ureteric occlusion during percutaneous nephrolithotripsy: the ‘counter‐flow’ principle

I. Romics, P. Nyirády, S. Lovász, 2004, BJU international.

Cyclophosphamide is contraindicated in patients with a history of transitional cell carcinoma

I. Romics, K. Kleinschmidt, D. Bach, 2005, Clinical Rheumatology.

Introduction: Symposium on “Terpenes in Urolithiasis,” Düsseldorf, Germany, September 2010

T. Knoll, I. Romics, 2010 .

The prognostic value of cadherin switch in bladder cancer.

M. Tötsch, K. Schmid, A. Eisenhardt, 2010, Oncology reports.

Detection of bladder cancer from the urine using fluorescencein situ hybridization technique

I. Kovalszky, Z. Nemeth, T. Szarvas, 2008, Pathology & Oncology Research.

[Prevention and treatment of erectile dysfunction after radical prostatectomy].

P. Riesz, I. Romics, P. Nyirády, 2009, Orvosi hetilap.

Angiogenic Switch of Angiopietins-Tie2 System and Its Prognostic Value in Bladder Cancer

I. Kovalszky, M. Tötsch, S. Ergün, 2008, Clinical Cancer Research.

The role of alpha-adrenoreceptors in the treatment of urological diseases

I. Romics, 2007, Neurochemistry International.

Circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancer.

H. Klingler, G. Kramer, S. Ergün, 2012, Urology.

Serum Levels of Angiogenic Factors and their Prognostic Relevance in Bladder Cancer

I. Kovalszky, S. Ergün, T. Szarvas, 2009, Pathology & Oncology Research.

Genetic profile of bone metastases in renal cell carcinoma.

K. Junker, P. Riesz, A. Szendrői, 2004, European urology.

The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial

T. Kiss, M. Wirth, B. Tombal, 2010, Journal of Translational Medicine.

antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial

T. Kiss, M. Wirth, B. Tombal, 2010 .

[Testicular cancer--diagnosis and treatment].

P. Riesz, I. Romics, M. Szűcs, 2008, Orvosi hetilap.

Apoptosis in untreated and hormone-treated prostate cancer of various histological types

I. Romics, L. Vass, Béla Szfnde, 2008, Pathology & Oncology Research.

Repeated biopsies in evaluation of therapeutic effects in prostate carcinoma

B. Szende, M. Bély, I. Romics, 2001, The Prostate.

Apoptosis, Mitosis, p53, bcl2, Ki-67 and Clinical Outcome in Prostate Carcinoma Treated by Androgen Ablation

B. Szende, Z. Szegedi, M. Bély, 1999, Urologia Internationalis.

[Conservative treatment of benign prostatic hyperplasia].

I. Romics, 2008, Orvosi hetilap.

Expression of p21waf1/cip1, p27kip1, p63 and Androgen Receptor in Low and High Gleason Score Prostate Cancer

B. Szende, I. Romics, E. Székely, 2008, Pathology & Oncology Research.

New diagnostic and prognostic examinations of malignant tumors of urinary bladder

I. Romics, A. Kovács, 2009 .

Claudins and Ki-67

P. Riesz, I. Romics, A. Kiss, 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

β‐catenin expression and claudin expression pattern as prognostic factors of prostatic cancer progression

A. Szász, A. Tőkés, J. Kulka, 2010, BJU international.

[Treatment of prostate cancer].

I. Romics, 2010, Orvosi hetilap.

Gene network and canonical pathway analysis in prostate cancer: a microarray study

B. Nagy, I. Romics, H. Savlı, 2008, Experimental & Molecular Medicine.

Penis covering and simultaneous urethral replacement by scrotal skin for severe penile and urethral necrosis

I. Romics, P. Nyirády, J. Barabás, 2008, International Urology and Nephrology.

A Special Terpene Combination (Rowatinex®) Improves Stone Clearance after Extracorporeal Shockwave Lithotripsy in Urolithiasis Patients: Results of a Placebo-Controlled Randomised Controlled Trial

R. Kohnen, I. Romics, J. Varga, 2010, Urologia Internationalis.

Improving Stone Clearance After Extracorporeal Shock Wave Lithotripsy in Urolithiasis Patients by a Special Terpene Combination (Rowatinex®): Results of a Placebo-Controlled, Randomized Trial

R. Kohnen, I. Romics, J. Varga, 2010 .

[Effects of bioactive molecules of Beta vulgaris L. ssp. esculenta var. rubra on metastatic prostate cancer].

A. Horváth, A. Blázovics, I. Romics, 2010, Orvosi hetilap.

Phytotherapy Adds to the Therapeutic Armamentarium for the Treatment of Mild-To-Moderate Lower Urinary Tract Symptoms in Men

P. Fornara, S. Madersbacher, I. Romics, 2019, Urologia Internationalis.

Study of cytotoxicity against adenovirally transformed cells in patients with tumours of the urinary tract

I. Romics, J. Horváth, 2005, International Urology and Nephrology.

Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.

I. Kovalszky, T. Szarvas, P. Riesz, 2007, Oncology reports.

Clinical observations with Cetiprin (emepronium bromide)

I. Romics, A. Hamvas, F. Balogh, 2005, International Urology and Nephrology.

The diagnosis and management of vesicovaginal fistulae

I. Romics, Z. Kelemen, Z. Fazakas, 2002, BJU international.

Changes of protein expression in prostate cancer having lost its androgen sensitivity

B. Szende, I. Romics, P. Nyirády, 2015, International Urology and Nephrology.

A novel videomicroscopic technique for studying rat ureteral peristalsis in vivo

E. Monos, I. Romics, P. Nyirády, 2009, World Journal of Urology.

Investigation of anal sphincter function following Mainz pouch type II urinary diversion after radical cystectomy

P. Riesz, A. Szendrői, I. Romics, 2012, International Urology and Nephrology.

Ultrasound guided biopsy, a gold standard diagnostical test of the prostate cancer.

I. Romics, 2005, Acta chirurgica Iugoslavica.

The technique of ultrasound guided prostate biopsy

I. Romics, 2004, World Journal of Urology.

Clinical symptoms related to renal cell carcinoma are independent prognostic factors for intraoperative complications and overall survival

G. Haas, P. Riesz, A. Szendrői, 2009, International Urology and Nephrology.

Zn, Ca and Na levels in the prostatic secretion of patients with prostatic adenoma

I. Romics, D. Bach, 2006, International Urology and Nephrology.

Expression of Claudins and Their Prognostic Significance in Noninvasive Urothelial Neoplasms of the Human Urinary Bladder

J. Tímár, P. Riesz, I. Romics, 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

7117 POSTER Claudins and Ki-67 – Potential Markers to Differentiate Low and High Grade Transitional Cell Carcinomas of the Urinary Bladder

P. Riesz, I. Romics, P. Nyirády, 2011 .

The prognostic value of prostate specific antigen in the follow-up of patients after radical prostatectomy

I. Romics, D. Bach, U. Würz, 2007, International Urology and Nephrology.

Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene

K. Ickstadt, T. Reckwitz, M. Falkenstein, 2011, Archives of Toxicology.

A surgical case of Grawitz's tumour of cystous appearance

I. Romics, J. Horváth, V. Szabó, 2005, International Urology and Nephrology.

Less invasive treatment option for renal carcinoma with venous tumor thrombus

A. Szendrői, I. Romics, Z. Nagy, 2014, Croatian medical journal.

Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival

H. Reis, C. Niedworok, T. Szarvas, 2017, Pathology & Oncology Research.

Spectrographic determination of zinc in the tissues of adenoma and carcinoma of the prostate

I. Romics, L. Katchalova, 2005, International Urology and Nephrology.

Study of nonspecific lymphocyte transformation in urologic cancer patients

I. Romics, J. Horváth, 2005, International Urology and Nephrology.

[Experiences in treatment and follow up of 50 patients with penile cancer].

P. Riesz, A. Szendrői, I. Romics, 2007, Orvosi hetilap.

Improving diagnostic accuracy of prostate carcinoma by systematic random map-biopsy

B. Szende, I. Romics, T. Kerényi, 2009, Pathology & Oncology Research.

Immune studies by the use of Multitest-Merieux in patients with kidney tumours

I. Romics, G. Kulcsár, P. Brühl, 2006, International Urology and Nephrology.

Effect of levamisol on cellular and humoral immune reactivity and on recurrences in patients with bladder papilloma

J. Féher, I. Romics, Á. Csontai, 2005, International Urology and Nephrology.

The investigation of cellular and humoral immune reactivity in patients with tumours of the bladder

J. Féher, I. Romics, L. Kisbenedek, 2005, International Urology and Nephrology.

Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk

K. Ickstadt, T. Reckwitz, M. Falkenstein, 2010, Archives of Toxicology.

A case of bilateral testicular lymphoma

B. Szende, M. Bély, I. Romics, 1999, Pathology & Oncology Research.

[Diagnosis and treatment of primary testicular non-Hodgkin lymphoma].

I. Romics, P. Nyirády, M. Romics, 2014, Orvosi hetilap.

Changes in prostate-specific antigen and prostatic acid phosphatase concentration following prostatic examination in benign prostatic hypertrophy and prostate cancer patients.

I. Romics, L. Galamb, 1992, European urology.

E-Cadherin expression in transitional cell carcinomas

P. Riesz, I. Romics, Virág Török, 2008, Pathology & Oncology Research.

Prognostic Factors and Survival of Renal Clear Cell Carcinoma Patients with Bone Metastases

Z. Nemeth, M. Szendrői, A. Szendrői, 2010, Pathology & Oncology Research.

A novel approach to the treatment of benign prostatic hyperplasia

I. Romics, K. Horváth, A. Varga, 2006, BJU international.

Real‐time flow resistance compensation for urodynamic examinations of the upper urinary tract through single lumen catheters

I. Romics, S. Lovász, 2008, International journal of urology : official journal of the Japanese Urological Association.

Is Radical Nephroureterectomy and Lymph Node Dissection Necessary for Upper-tract TCC?

S. Joniau, I. Romics, H. Poppel, 2010 .

Long-term psychological and sexual outcomes of severe penile hypospadias repair.

S. Kemény, I. Romics, A. Kiss, 2011, The journal of sexual medicine.

Bilateral renal cell carcinoma in a horseshoe kidney

P. Riesz, I. Romics, P. Nyirády, 2009, Pathology Oncology Research.

Observations with Depo-Provera (medroxyprogesterone) in the management of renal tumours

I. Romics, D. Répássy, 2006, International Urology and Nephrology.

A novel quantitative method for measuring obstruction in the upper urinary tract: The ‘obstruction coefficient’

L. Lovász, I. Romics, P. Nyirády, 2008, International journal of urology : official journal of the Japanese Urological Association.

Ureteral motility.

E. Monos, I. Romics, P. Nyirády, 2009, Acta physiologica Hungarica.

Treatment and outcome of vaseline-induced sclerosing lipogranuloma of the penis.

I. Romics, A. Kiss, P. Nyirády, 2010, Urology.

High insulin‐like growth factor mRNA‐binding protein 3 (IMP3) protein expression is associated with poor survival in muscle‐invasive bladder cancer

J. Fischer, A. Bankfalvi, K. Schmid, 2012, BJU international.

Analysis of Risk Factors for Urinary Incontinence after Radical Prostatectomy

P. Riesz, I. Romics, A. Majoros, 2007, Urologia Internationalis.

Follow-up of prostate carcinoma patients treated with total androgen blockade by repeated map-biopsy.

B. Szende, I. Romics, K. Bartók, 2000, Annales d'urologie.

Apoptosis in Prostate Carcinomas after Short‐Term Treatment with Decapeptyl

B. Szende, I. Romics, S. Lovász, 2003, Annals of the New York Academy of Sciences.

Substitution of the distal female urethra with a vaginal flap and pedicled skin island

I. Romics, Z. Kelemen, L. Pajor, 2002, BJU international.

Experience with hormone receptors in renal cancer

I. Romics, D. Bach, C. Rüssel, 2006, International Urology and Nephrology.

Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy

A. Scherag, A. Bankfalvi, K. Schmid, 2011, International journal of cancer.

[Clinical and immunological studies in patients with prostatic tumors].

J. Féher, I. Romics, L. Kisbenedek, 1981, Zeitschrift fur Urologie und Nephrologie.

[Immune reactivity of patients with bladder tumors].

J. Féher, I. Romics, L. Kisbenedek, 1981, Orvosi hetilap.

[A case of renal hemangiopericytoma].

I. Romics, D. Bach, W. Beutler, 1988, Orvosi hetilap.

Preoperative staging and early postoperative complications in radical prostatectomy. Experiences in 35 cases

I. Romics, D. Bach, T. Widmann, 2007, International Urology and Nephrology.

Urinary matrix metalloproteinase‐7 level is associated with the presence of metastasis in bladder cancer

S. Ergün, T. Szarvas, P. Riesz, 2011, BJU international.

The influence of expertise of the surgical pathologist to undergrading, upgrading, and understaging of prostate cancer in patients undergoing subsequent radical prostatectomy

J. Kulka, P. Riesz, A. Szendrői, 2014, International Urology and Nephrology.

Signet-ring cell carcinoma arising from the urinary bladder.

A. Szendrői, I. Romics, E. Székely, 2008, The Canadian journal of urology.

[Investigation of prostate specific antigen in the first decade of its use, in our clinic (1994-2004)].

T. Glasz, I. Romics, E. Székely, 2007, Orvosi hetilap.

Significance of examination of prostate-specific antigen and prostate-specific antigen density in patients with prostatic hyperplasia and prostate cancer

I. Bodrogi, I. Romics, D. Frang, 2006, International Urology and Nephrology.

Observations with Bazoton® in the management of prostatic hyperplasia

I. Romics, 1987, International Urology and Nephrology.

DNA content of prostatic cancer measured by flow cytometry in patients undergoing radical prostatectomy.

I. Romics, J. Bocsi, L. Kopper, 1995, Anticancer research.

Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene

K. Ickstadt, T. Reckwitz, M. Falkenstein, 2012, Archives of Toxicology.

T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin.

I. Romics, J. Gschwend, D. Bach, 2003, Journal of Urology.

European Study of Radical Prostatectomy: time trends in Europe, 1993–2005

A. Zlotta, M. Marberger, V. Ravery, 2007, BJU international.

The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancer.

P. Lakatos, A. Szendrői, I. Romics, 2010, The Canadian journal of urology.

Management of congenital penile curvature.

I. Romics, P. Nyirády, A. Majoros, 2008, The Journal of urology.

Voiding Symptoms and Urodynamic Findings in Patients with Modified Ileal Neobladde

I. Romics, P. Nyirády, A. Majoros, 2009, Pathology & Oncology Research.

Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer

S. Ergün, H. Reis, T. Szarvas, 2012, International journal of cancer.

Bladder cancer documentation of causes: multilingual questionnaire, 'bladder cancer doc'.

J. Hengstler, T. Ecke, R. D. Mittal, 2012, Frontiers in bioscience.

Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk

K. Ickstadt, T. Reckwitz, M. Falkenstein, 2012, Archives of Toxicology.

Apoptosis in prostate cancer after hormonal treatment

B. Szende, I. Romics, L. Vass, 1993, The Lancet.

Study of hydroxyproline excretion in patients with prostatic cancer

I. Romics, L. Kisbenedek, I. Budavári, 2005, International Urology and Nephrology.

[Value of testing the abdominal leak point pressure in the differential diagnosis of urinary stress incontinence].

I. Romics, A. Majoros, A. Keszthelyi, 2003, Orvosi hetilap.

Mucoepidermoid Lung Tumor Appearing as an Abscess on the Scrotum

A. Szendrői, I. Romics, E. Székely, 2009, Urologia Internationalis.

[Zinc, calcium and sodium values in secretions of patients with benign prostatic hyperplasia].

I. Romics, D. Bach, 1990, Zeitschrift fur Urologie und Nephrologie.

[Treatment of benign prostate hyperplasia].

I. Romics, 2010, Orvosi Hetilap.

The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancer.

P. Lakatos, A. Szendrői, I. Romics, 2011, The Canadian journal of urology.

Expression of Claudins and Their Prognostic Significance in Noninvasive Urothelial Neoplasms of the Human Urinary Bladder

J. Tímár, P. Riesz, I. Romics, 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Chromosomal Aneuploidy in Azoospermic Men

P. Sótonyi, I. Romics, E. Csonka, 2006 .

[Can inverted papilloma in urinary bladder be considered as a benign tumor].

P. Riesz, A. Szendrői, I. Romics, 2010, Orvosi hetilap.

Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer

S. Ergün, H. Reis, T. Szarvas, 2012, International journal of cancer.